Testing effectiveness (Phase 2)Active Not RecruitingNCT05684276What this trial is testingDUMAS: Neo-Adjuvant Immunotherapy for Pancoast TumorsWho this might be right forNSCLCPancoast Tumor Fundación GECP 22
Testing effectiveness (Phase 2)Study completedNCT00002642What this trial is testingSWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung CancerWho this might be right forLung Cancer SWOG Cancer Research Network 116
Testing effectiveness (Phase 2)UnknownNCT06331455What this trial is testingTreatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and ResectionWho this might be right forLung Cancer PatientsNon-small Cell Lung Cancer (NSCLC) Marc de Perrot 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT04465968What this trial is testingEfficacy and Safety of CRT, Durvalumab and Surgery for SSTWho this might be right forSuperior Sulcus TumorNon-small Cell Lung Cancer Stage IIBNon Small Cell Lung Cancer Stage III National Cancer Center Hospital East 84
Testing effectiveness (Phase 2)Study completedNCT00984997What this trial is testingCombined Modality Treatment for Resectable Non-Small Cell Superior Sulcus TumorsWho this might be right forLung Cancer M.D. Anderson Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT00062439What this trial is testingS0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast TumorsWho this might be right forLung Cancer SWOG Cancer Research Network 46
Early research (Phase 1)Study completedNCT00413322What this trial is testingStudy of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsWho this might be right forTumor Valerio Therapeutics 35
Testing effectiveness (Phase 2)Study completedNCT00128037What this trial is testingTrial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806)Who this might be right forPulmonary Neoplasm Japan Clinical Oncology Group 75